by In2Pharma | Jun 27, 2023 | News
Europe EMA has published recommendations for industry on good practices to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact . Medicine shortages are a global health problem and are increasingly affecting European...
by In2Pharma | Aug 10, 2021 | News
Europe On 3 June, MedTech Europe published a Guidance on the Interactions between the Medical Technology Industry and Patient Organisations (PO). The aim of this Guidance is to explain the rationale underpinning current interactions between the MedTech industry and PO...
by In2Pharma | Mar 30, 2021 | News
The Netherlands As from 1 January 2021, there is a new national reporting point for healthcare professionals (i.e. doctors, pharmacists…) to report any kind of incidents with medication: from errors in the prescription up to the administration of medicines, including...
by In2Pharma | Mar 29, 2021 | News
Europe Regulation (EU) 2019/515 on the mutual recognition of goods lawfully marketed in another Member State started to apply on 19 April 2020 and replaced Regulation (EC) No 764/2008. The aim of the Regulation is to strengthen the functioning of the single market by...
by In2Pharma | Jul 7, 2020 | News
Europe The European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have agreed on a series of measures to mitigate the impact of disruptions caused by COVID-19 on the conduct of inspections of manufacturing facilities or...
